N-Nitroso Oxcarbazepine EP Impurity H
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Oxcarbazepine is also sometimes used to treat bipolar disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of frenzied abnormal excitement, and other abnormal moods).N-Nitroso Oxcarbazepine EP Impurity H is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Oxcarbazepine EP Impurity H CAS NO:NA Chemically represented as10-Methoxy-5-nitroso-5H-dibenzo[b,f]azepine.Synchemia is the leading manufacturing and exporter of N-Nitroso Oxcarbazepine EP Impurity H.We supply N-Nitroso Oxcarbazepine EP Impurity H with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142964 |
| CAS No | NA |
| Mol.F. | C13H10FN3O2 |
| Mol.Wt. | 259.24 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142965 |
| CAS No | NA |
| Mol.F. | C22H18N8O2 |
| Mol.Wt. | 426.44 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142966 |
| CAS No | NA |
| Mol.F. | C21H15FN8O2 |
| Mol.Wt. | 430.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142967 |
| CAS No | NA |
| Mol.F. | C22H17FN8O2 |
| Mol.Wt. | 444.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142968 |
| CAS No | NA |
| Mol.F. | C39H32FN11O3 |
| Mol.Wt. | 721.76 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142969 |
| CAS No | NA |
| Mol.F. | C22H19FN8O3 |
| Mol.Wt. | 462.45 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142970 |
| CAS No | NA |
| Mol.F. | C20H25N3O5 |
| Mol.Wt. | 387.44 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142971 |
| CAS No | NA |
| Mol.F. | C16H16N2O5 |
| Mol.Wt. | 316.31 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142972 |
| CAS No | NA |
| Mol.F. | C17H18N2O5 |
| Mol.Wt. | 330.34 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142973 |
| CAS No | NA |
| Mol.F. | C20H25N3O6 |
| Mol.Wt. | 419.48 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142974 |
| CAS No | NA |
| Mol.F. | C11H13N3O2 |
| Mol.Wt. | 219.24 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142975 |
| CAS No | NA |
| Mol.F. | C19H23N3O4 |
| Mol.Wt. | 357.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142976 |
| CAS No | NA |
| Mol.F. | C25H24N2O8 |
| Mol.Wt. | 480.47 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142977 |
| CAS No | 2512237-43-1 |
| Mol.F. | C6H6N2O2 |
| Mol.Wt. | 138.1g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142978 |
| CAS No | NA |
| Mol.F. | C16H16ClN3O4S |
| Mol.Wt. | 393.84 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142979 |
| CAS No | NA |
| Mol.F. | C24H27N3O5 |
| Mol.Wt. | 437.50 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |